Message from the Program Director
Barry M. Cohen, MD, FACC
Director, Interventional Cardiology Fellowship Program
The interventional cardiologist is a key member of our heart team specializing in minimally invasive transcatheter therapies to promote prompt diagnosis and therapeutics for patients with coronary, valvular, structural heart and peripheral arterial diseases. The skills of diagnostic cardiac catheterization, PCI (with mechanical support when indicated) and structural intervention complement those of our heart team members including our colleagues in cardiac surgery, clinical and noninvasive cardiology, heart failure, electrophysiology and other health care professionals.
We are guideline- and data-driven, integrating clinical, laboratory, imaging and cardiac physiology information in our interventions. We employ a combination of this approach, the most advanced device technologies, the latest in pharmacotherapies and lifestyle modifications in order to repair coronary obstructions or structural defects. This is all with the aim of improving patients’ chances of survival and enhancing their qualities of life.
Our active participation in numerous state-of-the-art research trials gives our patients access to technologies before they become commercially available for clinical use.
At the completion of this one-year program, graduating fellows will be expert in all coronary diagnostic and interventional procedures as well as catheter based mechanical circulatory support.
Morristown Medical Center's Gagnon Cardiovascular Institute is home to New Jersey's largest cardiac surgery program. The organization ranked No. 20 on U.S. News & World Report's list of Best Hospitals for Cardiology & Heart Surgery for 2018-19.
Morristown Medical Center's cardiologists perform more than 5,000 cardiac catheterizations procedures and more than 2,400 coronary interventions each year. Morristown Medical Center heart surgeons perform more than 1,500 surgeries annually including more than 700 valve operations. The Valve Center is a national leader in percutaneous valve procedures and performed more than 600 TAVR procedures in 2019.